Shigeki Shimizu Selected Research

Shigeki Shimizu Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 08/2002
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2021 - 09/2002
18	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2021 - 01/2007
5	Adenocarcinoma 10/2017 - 02/2006
4	Carcinoma (Carcinomatosis) 04/2021 - 01/2014
4	Adenocarcinoma of Lung 01/2019 - 02/2006
2	Idiopathic Pulmonary Fibrosis 05/2021 - 07/2020
2	Fibrosis (Cirrhosis) 07/2020 - 12/2017
2	Disease Progression 05/2020 - 01/2014
2	Neoplasm Metastasis (Metastasis) 02/2020 - 02/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 08/2015
2	Melanoma (Melanoma, Malignant) 01/2016 - 05/2015
2	Thymoma (Thymic Carcinoma) 04/2014 - 03/2005
2	Fever (Fevers) 01/2012 - 01/2005
2	Malignant Mesothelioma 06/2011 - 05/2011
2	Sarcoidosis (Schaumann Disease) 03/2005 - 03/2004
1	Pneumonia (Pneumonitis) 05/2021
1	Sarcoma (Soft Tissue Sarcoma) 04/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2021
1	Burns 05/2020
1	Lymphoma (Lymphomas) 06/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2019
1	Amyloidosis 06/2019
1	Pneumoconiosis 12/2017
1	Carcinogenesis 12/2016
1	Epithelioid Hemangioendothelioma 11/2016
1	Infections 01/2016
1	Lipid Pneumonia 01/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2015
1	Pleural Effusion (Pleural Effusions) 01/2015
1	Synovial Sarcoma (Synovioma) 01/2015

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2006
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2015
4	LigandsIBA 01/2021 - 09/2003
4	ParaffinIBA 01/2021 - 01/2016
3	Immune Checkpoint InhibitorsIBA 05/2021 - 12/2016
3	Formaldehyde (Formol)FDA Link 01/2021 - 08/2017
3	Phosphotransferases (Kinase)IBA 09/2015 - 02/2009
3	Gemcitabine FDA Link 01/2014 - 10/2007
3	Gefitinib (Iressa)FDA Link 02/2009 - 01/2006
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 07/2010
2	alectinibIBA 05/2018 - 08/2015
2	Estrogen ReceptorsIBA 12/2016 - 01/2016
2	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2016 - 08/2002
2	Ifosfamide FDA LinkGeneric 01/2015 - 03/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2014 - 09/2002
2	CrizotinibIBA 06/2014 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 04/2014 - 01/2014
2	Etoposide (VP 16)FDA LinkGeneric 04/2014 - 03/2005
2	Equilibrative Nucleoside Transporter 1IBA 01/2014 - 10/2007
2	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 11/2003
2	Chemokine ReceptorsIBA 06/2007 - 09/2003
2	Biological ProductsIBA 11/2003 - 09/2003
1	PeriostinIBA 05/2021
1	integrin-linked kinaseIBA 04/2021
1	Fibronectins (Fibronectin)IBA 04/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2021
1	capmatinibIBA 01/2021
1	Periodic AcidIBA 07/2020
1	AsbestosIBA 07/2020
1	traferminIBA 05/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2020
1	SynaptophysinIBA 02/2020
1	Keratins (Keratin)IBA 02/2020
1	Amyloid (Amyloid Fibrils)IBA 06/2019
1	pembrolizumabIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 10/2018
1	ceritinibIBA 05/2018
1	Anaplastic Lymphoma KinaseIBA 05/2018
1	IndiumIBA 12/2017
1	CholesterolIBA 12/2017
1	Carcinoembryonic AntigenIBA 10/2017
1	NivolumabIBA 12/2016
1	Tobacco Smoke Pollution (Passive Smoking)IBA 12/2016
1	Bevacizumab (Avastin)FDA Link 11/2016
1	Carboplatin (JM8)FDA LinkGeneric 11/2016
1	Pemetrexed (MTA)FDA Link 11/2016
1	AntibodiesIBA 01/2016
1	VimentinIBA 01/2016
1	VemurafenibIBA 05/2015
1	CytokinesIBA 10/2014

Therapy/Procedure

14	Therapeutics 03/2021 - 08/2002
7	Drug Therapy (Chemotherapy) 11/2016 - 03/2005
3	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 03/2005
3	Radiotherapy 01/2015 - 01/2005
1	Precision Medicine 01/2021
1	Conservative Treatment 05/2020
1	Debridement 05/2020
1	Adjuvant Chemotherapy 02/2020
1	Nephrectomy 02/2020
1	Immunotherapy 01/2019
1	Molecular Targeted Therapy 08/2017
1	Sternotomy 12/2016
1	Lasers (Laser) 05/2015